These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26991939)

  • 1. 2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosis.
    Shukla L; Ajram LA; Begg M; Evans B; Graves RH; Hodgson ST; Lynn SM; Miah AH; Percy JM; Procopiou PA; Richards SA; Slack RJ
    Eur J Med Chem; 2016 Jun; 115():14-25. PubMed ID: 26991939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.
    Ajram L; Begg M; Slack R; Cryan J; Hall D; Hodgson S; Ford A; Barnes A; Swieboda D; Mousnier A; Solari R
    Eur J Pharmacol; 2014 Apr; 729(100):75-85. PubMed ID: 24534492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent CCR4 antagonists: synthesis, evaluation, and docking study of 2,4-diaminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hattori K; Miyazaki T; Ogino S; Orita M; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2008 Sep; 16(17):7968-74. PubMed ID: 18694645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2008 Jul; 16(14):7021-32. PubMed ID: 18539035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of a series of pyrido[2,3-d]pyrimidine derivatives as CCR4 antagonists.
    Gong H; Qi H; Sun W; Zhang Y; Jiang D; Xiao J; Yang X; Wang Y; Li S
    Molecules; 2012 Aug; 17(8):9961-70. PubMed ID: 22907157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.
    Miah AH; Champigny AC; Graves RH; Hodgson ST; Percy JM; Procopiou PA
    Bioorg Med Chem; 2017 Oct; 25(20):5327-5340. PubMed ID: 28801066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, syntheses, and SAR of 2,8-diazaspiro[4.5]decanones as T-type calcium channel antagonists.
    Fritch PC; Krajewski J
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6375-8. PubMed ID: 20934333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead identification of benzimidazolone and azabenzimidazolone arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.
    Miah AH; Abas H; Begg M; Marsh BJ; O'Flynn DE; Ford AJ; Percy JM; Procopiou PA; Richards SA; Rumley SA
    Bioorg Med Chem; 2014 Aug; 22(15):4298-311. PubMed ID: 24909677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Kysil VM; Mitkin OD; Tkachenko SE; Okun I
    Bioorg Med Chem; 2011 Feb; 19(4):1482-91. PubMed ID: 21277782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hamaguchi W; Yamasaki S; Koganemaru Y; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2009 Jan; 17(1):64-73. PubMed ID: 19081254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and SAR study of novel trisubstituted pyrimidine amide derivatives as CCR4 antagonists.
    Xu L; Zhang Y; Dai W; Wang Y; Jiang D; Wang L; Xiao J; Yang X; Li S
    Molecules; 2014 Mar; 19(3):3539-51. PubMed ID: 24662072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of the new orally active CCR4 antagonist K327 on CCR4+CD4+ T cell migration into the lung of mice with ovalbumin-induced lung allergic inflammation.
    Sato T; Komai M; Iwase M; Kobayashi K; Tahara H; Ohshima E; Arai H; Miki I
    Pharmacology; 2009; 84(3):171-82. PubMed ID: 19713720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure activity relationships of fused bicyclic and urea derivatives of spirocyclic compounds as potent CCR1 antagonists.
    Hossain N; Mensonides-Harsema M; Cooper ME; Eriksson T; Ivanova S; Bergström L
    Bioorg Med Chem Lett; 2014 Jan; 24(1):108-12. PubMed ID: 24332486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Kovalenko SM; Mitkin OD; Okun IM; Ravnyeyko IM; Tkachenko SE; Zaremba OV
    Bioorg Med Chem; 2010 Jul; 18(14):5282-90. PubMed ID: 20541425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization of CCR4 and inhibition of chemotaxis by K777, a potent and selective CCR4 antagonist.
    Sato T; Iwase M; Miyama M; Komai M; Ohshima E; Asai A; Yano H; Miki I
    Pharmacology; 2013; 91(5-6):305-13. PubMed ID: 23751403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antihypertensive activity of a series of 8-substituted 1-oxa-3,8-diazaspiro[4.5]decan-2-ones.
    Caroon JM; Clark RD; Kluge AF; Nelson JT; Strosberg AM; Unger SH; Michel AD; Whiting RL
    J Med Chem; 1981 Nov; 24(11):1320-8. PubMed ID: 7310808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity ligands and potent antagonists for the α1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.
    Romeo G; Salerno L; Pittalà V; Modica MN; Siracusa MA; Materia L; Buccioni M; Marucci G; Minneman KP
    Eur J Med Chem; 2014 Aug; 83():419-32. PubMed ID: 24992070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
    Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
    Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist.
    DeMong D; Dai X; Hwa J; Miller M; Lin SI; Kang L; Stamford A; Greenlee W; Yu W; Wong M; Lavey B; Kozlowski J; Zhou G; Yang DY; Patel B; Soriano A; Zhai Y; Sondey C; Zhang H; Lachowicz J; Grotz D; Cox K; Morrison R; Andreani T; Cao Y; Liang M; Meng T; McNamara P; Wong J; Bradley P; Feng KI; Belani J; Chen P; Dai P; Gauuan J; Lin P; Zhao H
    J Med Chem; 2014 Mar; 57(6):2601-10. PubMed ID: 24527772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.